Jayanta R Chowdhury

Title: The Innovations of Jayanta R Chowdhury

Introduction

Jayanta R Chowdhury is a notable inventor based in New Rochelle, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of newborn jaundice. His innovative approach has led to the development of a patent that addresses this critical health issue.

Latest Patents

Chowdhury holds a patent for the "Treatment of newborn jaundice." This patent is based on the discovery that the human bilirubin/phenol UDP-glucuronosyltransferase ugt1 gene complex contains an electrophile responsive element. The patent also utilizes knowledge from the rat NADP(H):quinone reductase gene, which contains an electrophile responsive element. Agents that double the quinone reductase specific activity of Hepa 1clc7 cells, such as BHT and sulforaphane, are used for the prophylaxis or treatment of newborn jaundice. He has 1 patent to his name.

Career Highlights

Throughout his career, Chowdhury has worked with prestigious institutions, including Cornell University and Albert Einstein College of Medicine. His work has been instrumental in advancing medical research and treatment methodologies.

Collaborations

One of his notable collaborators is Andrew J Dannenberg. Their partnership has contributed to the development of innovative solutions in the medical field.

Conclusion

Jayanta R Chowdhury's contributions to the treatment of newborn jaundice highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire future advancements in medical research and treatment.